LowEr Administered Dose With highEr Relaxivity: Gadovist vs Dotarem
Phase of Trial: Phase IV
Latest Information Update: 23 Dec 2018
At a glance
- Drugs Gadobutrol (Primary) ; Gadoterate-meglumine
- Indications CNS cancer
- Focus Diagnostic use
- Acronyms LEADER75
- Sponsors Bayer
- 25 Oct 2018 Status changed from not yet recruiting to recruiting.
- 25 Sep 2018 Planned initiation date changed from 31 Aug 2018 to 30 Sep 2018.
- 30 Aug 2018 Planned initiation date changed from 15 Aug 2018 to 31 Aug 2018.